We are pleased to inform you that, on the 21st of February  2020, iVis Technologies received the CE Certification (awarded in compliance with the MDD 93/42/EEC European directive) for the commercialization of SafeCross™ medical device.

SafeCross™ is an innovative riboflavin ophthalmic solution, specifically designed for corneal cross-linking in thin corneas, to treat ectatic diseases  with the iVis Technologies’ proprietary combined technique of customized transepithelial laser corneal remodeling and crosslinking.